COX-2s Left Out Of Drug Classes, Will Go Up Against Other NSAIDs
This article was originally published in The Pink Sheet Daily
Executive Summary
COX-2 inhibitors are among the drugs where Medicare coverage would be "recommended," but not required, under the U.S. Pharmacopeia's model formulary
You may also be interested in...
CMS Medicare Formulary Standards Will Have More “Granularity” Than USP
The Centers for Medicare & Medicaid Services expects its reviews of Medicare Rx drug plan formularies to include evaluation of drug choices at the “sub-class” level. The standards will also aim to encourage plans to provide more than the minimum two drugs per formulary class.
CMS Medicare Formulary Standards Will Have More “Granularity” Than USP
The Centers for Medicare & Medicaid Services expects its reviews of Medicare Rx drug plan formularies to include evaluation of drug choices at the “sub-class” level. The standards will also aim to encourage plans to provide more than the minimum two drugs per formulary class.
Cardiovascular Category Has 11 Classes, But Statins Not Among Them
Medicare drug formularies would not be required to cover a minimum number of cholesterol-lowering statin drugs under the U.S. Pharmacopeia's proposed model guidelines.